# BioHarvest Sciences Prepares Olive Cell Ingredient for CDMO Licensing

- URL: https://stocks.freetheai.org/news/bioharvest-sciences-prepares-olive-cell-ingredient-for-cdmo-licensing-f9aa53
- Published: 2026-10-13T11:00:00Z
- Category: company_news; sentiment: bullish; impact: medium
- Written by our AI from expert market sources across the web for FreeTheAI Stocks, built by Vibhek Soni
- How write-ups are made: https://stocks.freetheai.org/how-we-write
- Not financial advice: https://stocks.freetheai.org/disclaimer

BioHarvest Sciences Inc. (8MV0) has completed the development, scale-up, and regulatory preparation for its proprietary Olive Cell ingredient. The asset has achieved self-affirmed Generally Recognized as Safe status in the United States and is ready for Good Manufacturing Practice production. With industrial bioreactor scaling finished, the company is now offering Olive Cell for contract development and manufacturing organization licensing.

This milestone marks an effort by BioHarvest Sciences Inc. to broaden its revenue base beyond its flagship VINIA product. Achieving regulatory compliance and completing large-scale manufacturing testing reduces operational risks and shortens the timeframe required to start commercial shipments once partners sign supply agreements. Laboratory studies suggest potential applications for liver health, though clinical testing in humans has not yet been conducted.

Moving forward, the primary factor for investors to track will be whether the company secures signed licensing or distribution contracts with commercial partners to generate revenue from the product.

## Key points

- BioHarvest Sciences Inc. (8MV0) completed development and industrial bioreactor scale-up for its Olive Cell ingredient.
- The ingredient achieved self-affirmed Generally Recognized as Safe status and Good Manufacturing Practice readiness.
- Olive Cell is now available for commercial licensing through contract development and manufacturing partnerships.
- Preclinical tests suggest potential liver health benefits, but human efficacy studies remain pending.

## Questions and answers

### What is the latest update on BioHarvest Sciences Olive Cell ingredient?

BioHarvest Sciences completed development, industrial scale-up, and regulatory preparation for Olive Cell, making it ready for commercial licensing and production.

### Has Olive Cell received regulatory approval in the United States?

The ingredient achieved self-affirmed Generally Recognized as Safe status, which eases its entry into the United States market for intended uses.

### Has Olive Cell been tested in human clinical trials?

Preclinical laboratory studies showed potential benefits for liver health, but human clinical efficacy has not yet been established.